Group One Trading’s Immunocore IMCR Stock Holding History

Group One Trading’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$476K	Buy	+15,000	New	+$444K	﹤0.01%	3541
2025 Q2	–	Sell	-5,000	Closed	-$148K	–	8245
2025 Q1	$148K	Buy	+5,000	New	+$150K	﹤0.01%	4258
2024 Q4	–	Sell	-5,000	Closed	-$156K	–	7587
2024 Q3	$156K	Sell	5,000 -6,300	-56%	-$229K	﹤0.01%	3841
2024 Q2	$383K	Sell	11,300 -19,700	-64%	-$1M	﹤0.01%	2817
2024 Q1	$2.02M	Buy	31,000 +20,600	+198%	+$1.41M	0.01%	1473
2023 Q4	$711K	Buy	10,400 +9,100	+700%	+$473K	﹤0.01%	2778
2023 Q3	$67.5K	Sell	1,300 -1,600	-55%	-$94.7K	﹤0.01%	4821
2023 Q2	$174K	Sell	2,900 -9,000	-76%	-$514K	﹤0.01%	4088
2023 Q1	$588K	Buy	11,900 +1,300	+12%	+$73.1K	﹤0.01%	2613
2022 Q4	$605K	Buy	+10,600	New	+$597K	﹤0.01%	2871

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Group One Trading's IMCR Position: Q2 2026 in Review

Group One Trading increased its Immunocore (IMCR) stake by 1,919% in Q2 2026, buying an estimated $56.8K and bringing the position to 2,019 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5196.

Group One Trading first reported a position in IMCR in Q3 2022 and has held it in 7 quarters since. The position peaked at $569K in Q3 2024. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Group One Trading held 2,019 shares of Immunocore worth $64.1K as of Q2 2026.
Group One Trading bought 1,919 Immunocore shares in Q2 2026, an estimated $56.8K.
Immunocore made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5196 holding.
Group One Trading first reported a position in Immunocore in Q3 2022 and has held it in 7 quarters since.
Group One Trading's Immunocore position peaked at $569K in Q3 2024.
135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.